Elías Campo Güerri-rekin lankidetzan egindako argitalpenak (71)

2024

  1. Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma

    Blood Cancer Journal, Vol. 14, Núm. 1

  2. MYC-rearranged mature B-cell lymphomas in children and young adults are molecularly Burkitt Lymphoma

    Blood Cancer Journal, Vol. 14, Núm. 1

  3. Testicular large B-cell lymphoma is genetically similar to PCNSL and distinct from nodal DLBCL

    HemaSphere, Vol. 8, Núm. 10

2023

  1. Decoding the molecular heterogeneity of pediatric monomorphic post–solid organ transplant lymphoproliferative disorders

    Blood, Vol. 142, Núm. 5, pp. 434-445

  2. Intravascular Large B-Cell Lymphoma Genomic Profile Is Characterized by Alterations in Genes Regulating NF-κB and Immune Checkpoints

    American Journal of Surgical Pathology, Vol. 47, Núm. 2, pp. 202-211

  3. MALAT1 expression is associated with aggressive behavior in indolent B-cell neoplasms

    Scientific Reports, Vol. 13, Núm. 1

  4. Molecular diagnostics for vitreoretinal lymphoma

    Pathologie, Vol. 44, pp. 150-154

2022

  1. A unifying hypothesis for PNMZL and PTFL: morphological variants with a common molecular profile

    Blood Advances, Vol. 6, Núm. 16, pp. 4661-4674

  2. Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangements

    Blood Advances, Vol. 6, Núm. 7, pp. 2361-2372

  3. Diverse mutations and structural variations contribute to Notch signaling deregulation in paediatric T-cell lymphoblastic lymphoma

    Pediatric Blood and Cancer, Vol. 69, Núm. 11

  4. Genomic profiling for clinical decision making in lymphoid neoplasms

    Blood

  5. Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma

    British Journal of Haematology, Vol. 196, Núm. 3, pp. 589-598

  6. The molecular hallmarks of primary and secondary vitreoretinal lymphoma

    Blood Advances, Vol. 6, Núm. 5, pp. 1598-1607

2021

  1. MAPK and JAK-STAT pathways dysregulation in plasmablastic lymphoma

    Haematologica, Vol. 106, Núm. 10, pp. 2682-2693

2020

  1. Cryptic insertions of the immunoglobulin light chain enhancer region near CCND1 in t(11;14)-negative mantle cell lymphoma

    Haematologica

  2. Distinct molecular profile of IRF4-rearranged large B-cell lymphoma

    Blood, Vol. 135, Núm. 4, pp. 274-286

  3. Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease

    Blood Advances, Vol. 4, Núm. 22, pp. 5652-5665

2019

  1. Burkitt-like lymphoma with 11q aberration: A germinal center-derived lymphoma genetically unrelated to Burkitt lymphoma

    Haematologica, Vol. 104, Núm. 9, pp. 1822-1829

  2. CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D12 mantle cell lymphoma

    Blood, Vol. 133, Núm. 9, pp. 940-951

  3. Expression of the transcribed ultraconserved region 70 and the related long non-coding RNA AC092652.2-202 has prognostic value in Chronic Lymphocytic Leukaemia

    British Journal of Haematology